Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
E-pub ahead of print

Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Plasma somatostatin in advanced heart failure: association with cardiac filling pressures and outcome

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A Novel SCN5A Variant Associated with Abnormal Repolarization, Atrial Fibrillation, and Reversible Cardiomyopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Common genetic variants and risk of ischemic heart failure: an evaluation of a negative genetic study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Lars Kjøller-Hansen
  • Henning Kelbæk
  • Evald Høj Christiansen
  • Peter Riis Hansen
  • Thomas Engstrøm
  • Anders Junker
  • Niels Bligaard
  • Jørgen Lykke Jeppesen
  • Anders Michael Galløe
View graph of relations

INTRODUCTION: The predictors of stent treatment failure and their importance 10 years after treatment with drug-eluting stents (DESs) have not been reported in detail.

METHODS: Data were retrieved from the SORT-OUT II database encompassing 2,849 non-left main coronary lesions in 2,073 unselected all-comer patients treated with first-generation DES and followed clinically for 10 years. Stent treatment failure (STF) was defined as definite or probable stent thrombosis, target lesion revascularization (TLR), or >70% restenosis left untreated. Target lesion failure (TLF) was defined as cardiac death, target vessel myocardial infarction, or TLR. Characteristics predicting higher hazard ratios (HRs) were identified by the multivariate Cox regression analysis.

RESULTS: A stent diameter ≤2.5 versus ≥3.5 mm had STF 23.3 versus 11.8% and TLF 27.9 versus 18.8%. Stent length <20 versus >40 mm had STF 13.0 versus 29.0% and TLF 18.7 versus 34.6%. In multivariate analysis, decreasing stent diameter (HR: 1.24 [3.0 mm] to 2.12 [2.25 mm], reference ≥3.5 mm) and increasing stent length (HR: 1.15 [20-30 mm] to 2.07 [>40 mm], reference <20 mm) predicted STF together with diabetes (HR: 1.31), previous revascularization (HR: 1.31), restenotic (HR: 2.25), bifurcation (HR: 1.45), and chronically occluded lesions (HR: 1.54). A predictive score (PS) was calculated for each lesion from the HRs for the predictors present. The 10-year rates of STF were 10% in lesions with a PS ≤ 1.5 and 37% in those with PS ≥ 3.5.

CONCLUSIONS: Ten-year outcomes show large variations depending on the stent size and a few patient and lesion characteristics. The calculation of a PS from these unambiguous variables may be used to improve the risk estimate in individual lesions and patients.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
Publication statusE-pub ahead of print - 3 Aug 2021

    Research areas

  • Coronary artery disease, PCI, PTCA, Predictors, Restenosis, PTCA/PCI

ID: 66975267